AMETEK(AME)2025-02-04 16:41Financial Performance - AMETEK's Q4 2024 sales reached a record 469.0 million, with operating margins at 26.6%, up 90 basis points year-over-year[2] - Full year 2024 sales totaled 1.81 billion, up 6% from the previous year, with adjusted operating income margins at 26.1%[5] - Operating cash flow for the full year 2024 was 1.87, an 11% increase from Q4 2023[3] - Diluted earnings per share (GAAP) for Q4 2024 was 1.48 in Q4 2023, representing a 12.8% increase[27] - Adjusted diluted earnings per share (Non-GAAP) for Q4 2024 was 1.68 in Q4 2023, reflecting an 11.3% growth[27] - For the year ended December 31, 2024, diluted earnings per share (GAAP) increased to 5.67 in 2023, a rise of 4.6%[27] - The forecasted diluted earnings per share (GAAP) for Q1 2025 is projected to be between 1.48[27] - The forecasted adjusted diluted earnings per share (Non-GAAP) for Q1 2025 is expected to range from 1.69[27] Cash Flow - Free cash flow for Q4 2024 was a record 1.21 billion, down 2% from Q4 2023, while operating income increased 8% to 546.7 million, driven by the acquisition of Paragon Medical and growth in Aerospace and Defense sectors[9] Non-GAAP Financial Information - The company emphasizes the use of non-GAAP financial information to provide investors with greater insight into operational performance[29] - Non-GAAP measures are intended to enhance understanding of long-term profitability trends and facilitate comparisons with peers[30] - The reconciliation of non-GAAP measures to GAAP measures is included in the financial tables for transparency[29] Amortization and Tax - The company reported pretax amortization of acquisition-related intangible assets of 0.28 in Q1 2025 forecast[27] - The income tax benefit on amortization of acquisition-related intangible assets was $(0.07) for Q1 2025 forecast, consistent with the previous quarter[27]